Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

ReShape Lifesciences Inc., US67424L2097

ReShape Lifesciences Inc., US67424L2097

08.06.2021 - 13:32:53

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

dboateng@theruthgroup.com

SOURCE: ReShape Lifesciences Inc.

08.06.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

1205225??08.06.2021?

@ dgap.de